$22.25
-2.20[-9.00%]
At close: May 8
$22.25
0[0.00%]
After Hours: 7:03AM EDT
CervoMed
(NASDAQ:CRVO)CervoMed Stock (NASDAQ:CRVO), Analyst Ratings, Price Targets, Predictions
CervoMed Inc has a consensus price target of $65, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Canaccord Genuity and Canaccord Genuity on April 8, 2024 and February 15, 2024. With an average price target of $57.5 between Canaccord Genuity and Canaccord Genuity, there's an implied 158.43% upside for CervoMed Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CervoMed
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for CervoMed (CRVO)?
The latest price target for CervoMed (NASDAQ: CRVO) was reported by Canaccord Genuity on April 8, 2024. The analyst firm set a price target for $65.00 expecting CRVO to rise to within 12 months (a possible 192.13% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CervoMed (CRVO)?
The latest analyst rating for CervoMed (NASDAQ: CRVO) was provided by Canaccord Genuity, and CervoMed maintained their buy rating.
When was the last upgrade for CervoMed (CRVO)?
There is no last upgrade for CervoMed.
When was the last downgrade for CervoMed (CRVO)?
There is no last downgrade for CervoMed.
When is the next analyst rating going to be posted or updated for CervoMed (CRVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CervoMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CervoMed was filed on April 8, 2024 so you should expect the next rating to be made available sometime around April 8, 2025.
Is the Analyst Rating CervoMed (CRVO) correct?
While ratings are subjective and will change, the latest CervoMed (CRVO) rating was a maintained with a price target of $50.00 to $65.00. The current price CervoMed (CRVO) is trading at is $22.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.